Gilead Earnings, Revenue beat In Q2

  • Investing.com
  • Stock Market News
Gilead Earnings, Revenue beat In Q2
Credit: © Reuters.

Investing.com - Gilead (NASDAQ: GILD ) reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.

Gilead announced earnings per share of $1.87 on revenue of $6.22B. Analysts polled by Investing.com anticipated EPS of $1.73 on revenue of $6.09B.

Gilead shares are down 15% from the beginning of the year and are trading at $69.61 , down-from-52-week-high.They are under-performing the Nasdaq which is up 14.66% from the start of the year.

Gilead shares lost 0.32% in after-hours trade the report.

Gilead follows other major Healthcare sector earnings this month

Gilead's report follows an earnings beat by J&J on Wednesday, July 21, 2021, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.

UnitedHealth had beat expectations on Thursday, July 15, 2021 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100